These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21935923)

  • 1. Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.
    Kaluza KM; Thompson JM; Kottke TJ; Flynn Gilmer HC; Knutson DL; Vile RG
    Int J Cancer; 2012 Aug; 131(4):844-54. PubMed ID: 21935923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.
    Kaluza KM; Kottke T; Diaz RM; Rommelfanger D; Thompson J; Vile R
    Hum Gene Ther; 2012 Oct; 23(10):1054-64. PubMed ID: 22734672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.
    Wongthida P; Diaz RM; Pulido C; Rommelfanger D; Galivo F; Kaluza K; Kottke T; Thompson J; Melcher A; Vile R
    Hum Gene Ther; 2011 Nov; 22(11):1343-53. PubMed ID: 21366404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exuberated numbers of tumor-specific T cells result in tumor escape.
    Goldberger O; Volovitz I; Machlenkin A; Vadai E; Tzehoval E; Eisenbach L
    Cancer Res; 2008 May; 68(9):3450-7. PubMed ID: 18451173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
    Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
    Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.
    Le HK; Graham L; Miller CH; Kmieciak M; Manjili MH; Bear HD
    Cancer Immunol Immunother; 2009 Oct; 58(10):1565-76. PubMed ID: 19198835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expressing Akt in T cells to resist tumor immunosuppression and increase anti-tumor activity.
    Wu Y; Deng Z; Tang Y; Zhang S; Zhang YQ
    BMC Cancer; 2015 Aug; 15():603. PubMed ID: 26310246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer.
    Rommelfanger DM; Wongthida P; Diaz RM; Kaluza KM; Thompson JM; Kottke TJ; Vile RG
    Cancer Res; 2012 Sep; 72(18):4753-64. PubMed ID: 22836753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor gene therapy of established tumors in a murine melanoma model.
    Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
    J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.
    Bandyopadhyay S; Quinn TJ; Scandiuzzi L; Basu I; Partanen A; Tomé WA; Macian F; Guha C
    J Immunol; 2016 Feb; 196(4):1964-76. PubMed ID: 26755821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
    Galvan DL; O'Neil RT; Foster AE; Huye L; Bear A; Rooney CM; Wilson MH
    PLoS One; 2015; 10(10):e0140744. PubMed ID: 26473608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
    Hansen W; Hutzler M; Abel S; Alter C; Stockmann C; Kliche S; Albert J; Sparwasser T; Sakaguchi S; Westendorf AM; Schadendorf D; Buer J; Helfrich I
    J Exp Med; 2012 Oct; 209(11):2001-16. PubMed ID: 23045606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
    Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
    J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.
    Siurala M; Havunen R; Saha D; Lumen D; Airaksinen AJ; Tähtinen S; Cervera-Carrascon V; Bramante S; Parviainen S; Vähä-Koskela M; Kanerva A; Hemminki A
    Mol Ther; 2016 Aug; 24(8):1435-43. PubMed ID: 27357626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor.
    Tähtinen S; Grönberg-Vähä-Koskela S; Lumen D; Merisalo-Soikkeli M; Siurala M; Airaksinen AJ; Vähä-Koskela M; Hemminki A
    Cancer Immunol Res; 2015 Aug; 3(8):915-25. PubMed ID: 25977260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.